Mark R Christianson

Plymouth, MN, United States of America

Mark R Christianson

This inventor holds 146 USPTO granted patents and 28 published patent applications and 29 EPO patents, primarily in Medical Device Anchoring (CPC class A61M2025-0286). Top assignees: Interrad Medical, Inc., Vdyne, Inc., Tendyne Holdings, Inc.. Active years: 1994-2026.

USPTO Granted Patents = 146 

% Patents Active = 95.9

 

Average Co-Inventor Count = 3.4

ph-index = 24

Forward Citations = 1,937(Granted Patents)

Forward Citations (Not Self Cited) = 982(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Hutchinson, MN (US) (1994 - 1995)
  • Darwin, MN (US) (2003 - 2013)
  • Minneapolis, MN (US) (2015 - 2017)
  • Maple Grove, MN (US) (2020)
  • Eden Prairie, MN (US) (2022)
  • Plymouth, MN (US) (1998 - 2024)

Company Filing History:


Years Active: 1994-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Medical Devices
Anchoring Systems
Neurostimulation
Transcatheter Valves
Prosthetic Heart Valves
Intravenous Cannula
Cinch Device
Epicardial Anchors
Thrombus Management
Catheter Movement Detection
Mitral Valve Delivery
Retrieval Systems
146 patents (USPTO):Explore Patents

Title: Mark Christianson: Collaborating to Bring Inventions to Life

Introduction:

Mark Christianson, a prolific inventor based in Plymouth, MN, has made significant contributions to the field of medical device technology. With an impressive portfolio of patents and a proven ability to work effectively with given data, Christianson has gained recognition for his groundbreaking inventions in the healthcare sector. This article delves into his latest patented inventions, career highlights, and collaborations with prominent organizations.

Latest Patents:

Christianson's recent patents demonstrate his innovative thinking and expertise in medical device anchoring. One notable invention is the "Devices and Methods for Anchoring Transcatheter Heart Valve." This patent focuses on methods and devices for percutaneously anchoring a transcatheter heart valve, presenting potential advancements in minimally invasive cardiovascular procedures.

Furthermore, Christianson's patent for a "System for Anchoring Medical Devices" offers an innovative anchor device that secures a catheter without the need for sutures or skin tapes. The device can be adjusted to a folded condition, allowing for ease of removal while still maintaining subcutaneous anchors.

Career Highlights:

Having accumulated an impressive 120 patents, Christianson has made significant contributions to the medical device industry. Throughout his career, he has shown a remarkable ability to translate his ideas into practical solutions that address critical healthcare challenges.

Collaborations:

Christianson's achievements are not limited to individual endeavors. He has collaborated with several esteemed professionals and organizations, leveraging collective expertise to bring his inventions to life. Notably, Christianson has worked with companies such as Interrad Medical, Inc. and Vdyne, Inc., where he has undoubtedly contributed to their innovative product development.

In his collaborations, Christianson has teamed up with influential colleagues such as Michael S Rosenberg and Robert Vidlund. These partnerships have proven invaluable in fostering a collaborative environment, pooling resources, and bringing forth groundbreaking inventions.

Conclusion:

Mark Christianson is a true visionary in the field of medical device technology. With an extensive patent portfolio, he continually pushes the boundaries of innovation. Christianson's ability to effectively work with given data has enabled him to transform ideas into tangible solutions. Through collaborations with professionals and organizations, Christianson has exemplified the power of collective ingenuity in bringing his inventions to life. As he continues to make significant contributions to the medical field, Christianson's impact on patient care and healthcare practices promises to be long-lasting.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…